New Medtronic Micra AV pacemaker receives approval from the U.S. FDA
Category: #health  By Saipriya Iyer  Date: 2020-01-23
  • share
  • Twitter
  • Facebook
  • LinkedIn

New Medtronic Micra AV pacemaker receives approval from the U.S. FDA

Medtronic plc, a renowned US-based medical device company, reportedly announced that its Micra AV pacemaker has received approval from the U.S. FDA. The Medtronic Micra AV is the world’s smallest pacemaker with AV (atrioventricular) synchrony.

Micra AV pacemaker has been developed to treat patients suffering from AV block. This is a condition in which electrical signals between the heart chambers; the ventricle and the atria, are impaired. The company can now market its first-in-class and the only FDA-authorized leadless pacemaker portfolio, extending the number of potential candidates for this new groundbreaking technology across the U.S.

Cardiac electrophysiologist and Director of NYU Langone’s Heart Rhythm Center, New York City, Larry Chinitz, M.D., stated that with the Micra AV approval, a greater number of pacemaker patients can now qualify for a novel treatment option that delivers the benefits of leadless pacing. Benefits that include a minimally invasive implant process as well as a cosmetically invisible machine.

Chinitz further added that although complications with conventional pacemakers are not frequent, when they occur, they are quite expensive to treat and can also be invasive for a patient. Real-world usage of Micra has demonstrated a 63 percent reduction in bigger complications in comparison with conventional pacemakers.

Traditionally, patients suffering from AV block have received treatment through dual-chamber pacemakers that are implanted surgically in the upper chest, beneath the skin underneath the collar bone, and linked to the heart through a number of thin wires known as leads.

Similar in shape and size to the company’s Micra TPS (Transcatheter Pacing System), Micra AV has many extra internal atrial sensing algorithms that recognize cardiac movement, enabling the device to manage pacing inside the ventricle for further coordination with the atrium, offering AV synchronous pacing treatment to AV block patients.

Chief Medical Officer, Vice President of medical affairs at the Cardiac Rhythm and Heart Failure department, which is a part of the Medtronic Cardiac and Vascular Group, Rob Kowal, M.D., Ph.D. stated that since transforming medicine with the first-in-class cardiac pacemakers powered by battery, the company has continued to innovate better pacing technologies, which has culminated in the leadless pacing and first miniaturized portfolio for patients and physicians.

 

Source credit: http://newsroom.medtronic.com/news-releases/news-release-details/fda-approves-medtronic-micratm-av-worlds-smallest-pacemaker



About Author

Saipriya Iyer

Email: [email protected]   

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her bel...

Read More

More News By Saipriya Iyer

Copper3D unveils antimicrobial device to curb HIV risk via breastmilk
Copper3D unveils antimicrobial device to curb HIV risk via breastmilk
By Saipriya Iyer

Copper3D, a Chile- and U.S.-based antibacterial solutions provider, has recently worked on a project to create an antibacterial 3D printed device to mitigate the risk of HIV transmission during breastfeeding. The compa...

Tetra commences PoC clinical trial of PPP003v for companion dogs
Tetra commences PoC clinical trial of PPP003v for companion dogs
By Saipriya Iyer

Tetra Bio-Pharma Inc., a Canadian pharmaceutical firm that specializes in cannabinoid-derived drug therapy, has recently initiated a clinical study of synthetic cannabinoid therapy (PPP003v) for ophthalmic eye pain in ...

Satipharm begins clinical trial of CBD capsules for treating menopause
Satipharm begins clinical trial of CBD capsules for treating menopause
By Saipriya Iyer

Cannabis was prior considered to possess various medicinal benefits for treating diseases. However, after years of restriction, the scientific community is finally exploring the medical avenues of CBD by conducting adv...